Shopping Cart
Remove All
Your shopping cart is currently empty
Bidisomide (SC40230) is an agent of class I antiarrhythmic.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $115 | In Stock | In Stock | |
| 5 mg | $292 | In Stock | In Stock | |
| 10 mg | $429 | In Stock | In Stock | |
| 25 mg | $672 | In Stock | In Stock | |
| 50 mg | $888 | In Stock | In Stock | |
| 100 mg | $1,180 | In Stock | In Stock | |
| 500 mg | $2,380 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $322 | In Stock | In Stock |
| Description | Bidisomide (SC40230) is an agent of class I antiarrhythmic. |
| In vivo | Bidisomide's anti-arrhythmia effects. Bidisomide (5 mg/kg) reduces the number of premature ventricular complexes and the incidence of ventricular tachycardia and ventricular fibrillation similarly to Mexiletine (MXT) and Disopyramide (DSP) in rats with ventricular arrhythmias induced by coronary artery occlusion. After 5 minutes of coronary artery occlusion, the antiarrhythmic effect of 5 mg/kg Bidisomide was similar to the same dose of MXT and DSP in rats with ventricular arrhythmias caused by coronary reperfusion. All three drugs significantly slow the heart rate[1]. |
| Synonyms | SC40230 |
| Molecular Weight | 407.98 |
| Formula | C22H34ClN3O2 |
| Cas No. | 116078-65-0 |
| Smiles | CC(C)N(CCC(CCN1CCCCC1)(C(N)=O)c1ccccc1Cl)C(C)=O |
| Relative Density. | 1.124g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 225 mg/mL (551.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (12.26 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.